Risk Factors Associated with Spinal Cord Stimulation Failure in Patients with Chronic Pain: A Single-Center Retrospective Cohort Study
4 affiliations
- 1Department of General and Specialized Surgery, College of Medicine, Taibah University, Madinah 42353, Saudi Arabia
- 2Department of Surgery, King Faisal Specialist Hospital and Research Center, Madinah 42523, Saudi Arabia
- 3Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l’Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 3E4, Canada
- 4Department of Anaesthesiology and Pain Medicine, Chronic Pain Clinic, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC H2X 3E4, Canada
Abstract
Background/Objectives: Spinal cord stimulation (SCS) can provide long-term relief for selected patients with refractory chronic pain, but treatment failure may occur without device explantation. This study examined patient-, clinical-, and device-related factors associated with SCS failure after permanent implantation. Methods: This retrospective, single-center cohort study included 108 adults who underwent permanent SCS implantation at the Centre Hospitalier de l’Université de Montréal between 2007 and 2022. Failure was defined as completed or planned explantation, inadequate pain relief accompanied by a desire or plan for removal, or documented device non-use. Associations were evaluated using univariable categorical tests. Paired pain intensity and morphine milligram equivalent (MME) doses were compared using Wilcoxon signed-rank tests. Results: At the most recent documented assessment, composite SCS failure occurred in 40/108 patients (37.0%), and completed explantation occurred in 25/108 (23.1%); these proportions were not adjusted for unequal follow-up duration. The leading reasons for explantation were loss of efficacy (36.0%), paresthesia or dysesthesia (28.0%), and patient request (24.0%). In exploratory univariable analysis, smoking was associated with documented failure (RR = 1.70, 95% CI 1.05–2.75; p = 0.032). Failure differed across comorbidity-count categories (Cramér’s V = 0.34, 95% CI 0.00–0.48; p = 0.019), although the pattern was nonmonotonic. Neither association remained statistically significant after Benjamini–Hochberg correction across 26 comparisons (both q = 0.416). Sex, psychiatric history, pain duration, implantation approach, generator type, and generator location were not significantly associated with failure. The median within-patient reduction in pain intensity was 2.50 points (IQR, 1.00–5.00; p < 0.001), whereas the median paired MME change was 0 MME/day (IQR, −60 to 40; p = 0.649). Conclusions: A composite outcome identified a higher prevalence of clinically unsuccessful SCS treatment than completed explantation alone. Smoking showed an unadjusted association with documented failure; however, this finding may reflect confounding or chance arising from multiple comparisons and should be considered hypothesis-generating. Pain intensity improved without a corresponding significant reduction in opioid exposure. These findings require confirmation through prospective, prespecified multivariable and time-to-event analyses.
Related
- Occurrence Proportion and Associated Factors of Respiratory Failure During Hospitalization in Chinese Patients With AECOPD: A Systematic Review and Meta‐Analysis
- Electrolyte disturbance profiles and associated factors in Somali patients with heart failure
- Factors associated with 30-day mortality in patients with post-myocardial infarction ventricular septal rupture: a retrospective cohort study
- Treatment patterns and prognostic factors of radiation-associated esophageal fistula in patients with esophageal squamous cell carcinoma: a retrospective cohort study
- Primary Non-Adherence and Associated Factors in Patients with Atrial Fibrillation in Germany: A Retrospective Cohort Study
BibTeX
@article{osailan2026risk,
title = {{Risk Factors Associated with Spinal Cord Stimulation Failure in Patients with Chronic Pain: A Single-Center Retrospective Cohort Study}},
author = {Ahmed Osailan and Ahmed Najjar and Marie-Pierre Fournier-Gosselin and Francois Fugere},
journal = {Journal of clinical medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15197681},
url = {https://europepmc.org/article/PMC/PMC13666142},
note = {CC BY},
}
RIS
TY - JOUR
TI - Risk Factors Associated with Spinal Cord Stimulation Failure in Patients with Chronic Pain: A Single-Center Retrospective Cohort Study
AU - Ahmed Osailan
AU - Ahmed Najjar
AU - Marie-Pierre Fournier-Gosselin
AU - Francois Fugere
PY - 2026
DA - 2026/10/01
JO - Journal of clinical medicine
DO - 10.3390/jcm15197681
UR - https://europepmc.org/article/PMC/PMC13666142
AB - Background/Objectives: Spinal cord stimulation (SCS) can provide long-term relief for selected patients with refractory chronic pain, but treatment failure may occur without device explantation. This study examined patient-, clinical-, and device-related factors associated with SCS failure after permanent implantation. Methods: This retrospective, single-center cohort study included 108 adults who underwent permanent SCS implantation at the Centre Hospitalier de l’Université de Montréal between 2007 and 2022. Failure was defined as completed or planned explantation, inadequate pain relief accompanied by a desire or plan for removal, or documented device non-use. Associations were evaluated using univariable categorical tests. Paired pain intensity and morphine milligram equivalent (MME) doses were compared using Wilcoxon signed-rank tests. Results: At the most recent documented assessment, composite SCS failure occurred in 40/108 patients (37.0%), and completed explantation occurred in 25/108 (23.1%); these proportions were not adjusted for unequal follow-up duration. The leading reasons for explantation were loss of efficacy (36.0%), paresthesia or dysesthesia (28.0%), and patient request (24.0%). In exploratory univariable analysis, smoking was associated with documented failure (RR = 1.70, 95% CI 1.05–2.75; p = 0.032). Failure differed across comorbidity-count categories (Cramér’s V = 0.34, 95% CI 0.00–0.48; p = 0.019), although the pattern was nonmonotonic. Neither association remained statistically significant after Benjamini–Hochberg correction across 26 comparisons (both q = 0.416). Sex, psychiatric history, pain duration, implantation approach, generator type, and generator location were not significantly associated with failure. The median within-patient reduction in pain intensity was 2.50 points (IQR, 1.00–5.00; p < 0.001), whereas the median paired MME change was 0 MME/day (IQR, −60 to 40; p = 0.649). Conclusions: A composite outcome identified a higher prevalence of clinically unsuccessful SCS treatment than completed explantation alone. Smoking showed an unadjusted association with documented failure; however, this finding may reflect confounding or chance arising from multiple comparisons and should be considered hypothesis-generating. Pain intensity improved without a corresponding significant reduction in opioid exposure. These findings require confirmation through prospective, prespecified multivariable and time-to-event analyses.
SN - 2077-0383
ER -